Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-07-29 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 60978

Date	Daily Closing Price	Open	High	Low	Volume
29 Tue Jul 2025	3150.20	3083.50	3178.80	3083.50	1.623 times
28 Mon Jul 2025	3083.50	3144.20	3161.90	3072.50	0.9 times
25 Fri Jul 2025	3144.20	3175.00	3220.00	3120.40	1.895 times
24 Thu Jul 2025	3162.40	3130.00	3177.90	3100.00	1.13 times
23 Wed Jul 2025	3131.40	3121.90	3161.00	3090.00	0.965 times
22 Tue Jul 2025	3098.60	3134.00	3152.20	3088.00	0.905 times
21 Mon Jul 2025	3119.10	3138.40	3149.00	3074.10	0.886 times
18 Fri Jul 2025	3138.40	3184.00	3195.60	3112.50	0.861 times
17 Thu Jul 2025	3173.60	3170.00	3196.80	3154.90	0.76 times
16 Wed Jul 2025	3167.60	3198.00	3200.50	3153.90	0.752 times

My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 3128.1 as stoploss in an intra day buy trade for a target of 3199.31. However, stock will show a bearish move below 3128.1.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	2390.05
Downside Target	2693.90
Downside Target	2988.00
Downside Target	3072.50
Upside Target	3225.40
Upside Target	3254.90
Upside Target	3264.00
Upside Target	3358.90
Upside Target	3398.00
Upside Target	3450.00
Upside Target	3456.00
Upside Target	3515.70

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	3088.87
Downside Intraday Target	3027.53
Upside Intraday Target	3195.17
Upside Intraday Target	3240.13
Downside Intraday Target	3133.83

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
29 Tue Jul 2025	3150.20	3144.20	3178.80	3072.50	0.436 times
25 Fri Jul 2025	3144.20	3138.40	3220.00	3074.10	1.26 times
18 Fri Jul 2025	3138.40	3243.80	3254.90	3112.50	0.87 times
11 Fri Jul 2025	3243.80	3287.50	3358.90	3225.40	0.603 times
04 Fri Jul 2025	3283.70	3456.00	3456.00	3264.00	0.566 times

Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
29 Tue Jul 2025	3150.20	3388.70	3450.00	3072.50	0.45 times
30 Mon Jun 2025	3388.10	3298.00	3515.70	3153.90	0.557 times
30 Fri May 2025	3298.60	2935.30	3398.00	2693.90	1.338 times
30 Wed Apr 2025	2964.60	2872.00	3148.00	2401.00	1.438 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and the sell signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Glaxosmithkline Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 3138.09 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.